Innovation
Cambrex is a leader in the development and commercialization of small molecule therapeutics.
Experience
Cambrex has been providing solutions to small and large pharmaceutical companies for over 30 years.
Performance
Cambrex has an unwavering commitment to premium quality products and services.
Featured Story
Cambrex Launches Commercial Sufentanil and Sufentanil Citrate
Cambrex Corporation is pleased to announce that the development and validation of Sufentanil and Sufentanil Citrate have been completed and beginning in February 2012, Cambrex will begin supplying commercial quantities of each product to the marketplace.
Read more
Latest News RSS
Dec. 22, 2011
Cambrex VP Elected to SOCMA Board of Governors
Dec. 16, 2011
Cambrex Manufacturing Facility Receives MHRA Approval
Dec. 8, 2011
Cambrex to Exhibit at InformexUSA 2012
Investors RSS
Nov. 3, 2011
Cambrex Reports Third Quarter 2011 Results
Nov. 1, 2011
Cambrex to Announce Third Quarter 2011 Financial Results on November 3, 2011
Aug. 2, 2011
Cambrex Reports Second Quarter of 2011 Results
Contact Cambrex